arrow
G

Graciela M. Nogueras-González

the university of texas m d anderson cancer center
H指数:44
被引数:6,646

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy

用卡介苗或早期根治性膀胱切除术治疗欧洲泌尿外科协会极高危非肌层浸润性膀胱癌患者的肿瘤学结果

2023-12-0111
PRE
Impact of age >70 years on oncological outcomes in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guerin

年龄> 70岁对卡介苗治疗非肌层浸润性膀胱癌患者肿瘤学结局的影响

2023-08-028
PRE
Impact of type of induction therapy on outcomes in older adults with AML after allogeneic stem cell transplantation
2023-07-1410
OAAI
Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin-unresponsive Non-muscle-invasive Bladder Cancer: An Analysis of Long-term Survival Outcomes

卡介苗无反应的非肌层浸润性膀胱癌患者的保留膀胱治疗: 长期生存结果分析

2023-07-019
OAAI
Patient-reported Bowel Function and Bowel-related Quality of Life After Pelvic Radiation for Rectal Adenocarcinoma: The Impact of Radiation Fractionation and Surgical Resection
2023-06-018
OAAI
Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology

与MD Anderson IMPACT2精准肿瘤学随机研究相关的挑战和机遇

2022-10-2710
OAAI
Patient-Reported Bowel and Urinary Function in Long-Term Survivors of Squamous Cell Carcinoma of the Anus Treated With Definitive Intensity Modulated Radiation Therapy And Concurrent Chemotherapy
2022-09-0110
PRE
Updated European Association of Urology (EAU) Prognostic Factor Risk Groups Overestimate the Risk of Progression in Patients with Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guerin

更新的欧洲泌尿外科协会 (EAU) 预后因素风险组高估了卡介苗治疗的非肌层浸润性膀胱癌患者的进展风险

2022-02-0132
OA